Publication | Closed Access

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

MedicineUpdated ReportPathologyColorectal CancerMultiple Basket StudyPhase 2ACancer TreatmentOncologyRadiation Oncology